These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 5120379

  • 1. Adenocarcinoma of the uterine body following use of intrauterine contraceptive device.
    Harrison RF.
    Ir J Med Sci; 1971 Sep; 140(9):407-9. PubMed ID: 5120379
    [No Abstract] [Full Text] [Related]

  • 2. [Incidence of adenocarcinoma of the endometrium in association with intrauterine contraceptive device].
    Micko I.
    Cesk Gynekol; 1973 Jul; 38(6):439-41. PubMed ID: 4731609
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Case of cancer of the uterine body in a woman using IUD].
    Murakami A, Yamazaki K.
    Sanfujinka No Jissai; 1971 Nov; 20(12):1195-7. PubMed ID: 5172100
    [No Abstract] [Full Text] [Related]

  • 5. Endometrial morphology and polyethylene intrauterine devices. A study of 200 endometrial biopsies.
    Ober WB, Sobrero AJ, Kurman R, Gold S.
    Obstet Gynecol; 1968 Dec; 32(6):782-93. PubMed ID: 4193258
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Histological findings in IUD-induced tumors of the rat].
    Hölzl M, Haller J.
    Arch Gynakol; 1975 Nov 18; 219(1-4):45-6. PubMed ID: 1243421
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Leukocyte alkaline phosphatase activity in symptomatic users of intrauterine contraceptive devices.
    Santamaria-Urrego A, Epstein JA.
    Am J Obstet Gynecol; 1971 Jun 15; 110(4):461-6. PubMed ID: 5582001
    [No Abstract] [Full Text] [Related]

  • 11. [Cervico-uterine cancer and intra-uterine contraceptive devices (three new cases)].
    Riesco A, Monckeberg G.
    Rev Chil Obstet Ginecol; 1966 Jun 15; 31(5):266-79. PubMed ID: 5999152
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Intrauterine devices and uterine cancer--statistical re-evaluation of Ishibama's data].
    Ko D.
    Sanfujinka No Jissai; 1968 Jul 15; 17(7):606-14. PubMed ID: 5755143
    [No Abstract] [Full Text] [Related]

  • 17. [A case report of uterine hemorrhage following the insertion of the Medusa intrauterine contraceptive device in the presence of uterine adenomyosis].
    Cherveniashki S, Vasilev D.
    Akush Ginekol (Sofiia); 1990 Jul 15; 29(4):81-2. PubMed ID: 2267989
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Reliability and danger of intrauterine pessary].
    Philipp E, Luh W.
    Zentralbl Gynakol; 1972 Nov 18; 94(46):1569-75. PubMed ID: 4646053
    [No Abstract] [Full Text] [Related]

  • 20. Quantitative transcervical uterine cultures in asymptomatic women using an intrauterine contraceptive device.
    Hill JA, Talledo E, Steele J.
    Obstet Gynecol; 1986 Nov 18; 68(5):700-4. PubMed ID: 3531939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.